Journal
MOVEMENT DISORDERS
Volume 29, Issue 1, Pages 11-14Publisher
WILEY-BLACKWELL
DOI: 10.1002/mds.25759
Keywords
-
Categories
Funding
- Bayer Schering
- Biogen
- Boehringer Ingelheim
- Eisai
- Merck Sharp Dohme
- Novartis
- Lundbeck
- Sanofi-Aventis
- Sigma-Tau
- UCB Pharma
- Italian Minister of Health